Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

NCT00454168 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: PR1 leukemia peptide vaccine
BIOLOGICAL: sargramostim
OTHER: placebo

Sponsor

The Vaccine Company